Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Aptamer of methotrexate, aptamer derivative and application of aptamer and aptamer derivative

A technology of nucleic acid aptamer and methotrexate, applied in biological testing, biochemical equipment and methods, instruments, etc., can solve the problems of large toxic and side effects, narrow therapeutic window, endangering the life safety of patients, etc., and achieve small molecular weight, The effect of small batch variance and high stability

Active Publication Date: 2021-08-13
EAST CHINA NORMAL UNIV
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, MTX has the problems of narrow therapeutic window and large toxic and side effects. The adverse reactions induced by high-dose methotrexate (HDMTX) mainly include nephrotoxicity, bone marrow suppression, mucositis, gastrointestinal reactions and neurotoxicity. May endanger the life of the patient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aptamer of methotrexate, aptamer derivative and application of aptamer and aptamer derivative
  • Aptamer of methotrexate, aptamer derivative and application of aptamer and aptamer derivative
  • Aptamer of methotrexate, aptamer derivative and application of aptamer and aptamer derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Example 1: Methotrexate nucleic acid aptamer screening.

[0037] 1. Synthesize a random single-stranded DNA library (GGAGGCTCTCGGGACGACNNNNNNNNNNNNNNNNNNNNNNNNNNNNGTCGTCCCGATGCTGCAATCGTAA), a biotin-labeled complementary strand to the single-stranded DNA library (TCCCGAGAGCCTCCTTTT-Biotin), a forward primer (GGAGGCTCTCGGGACGAC) and a biotin-labeled reverse primer (GGCAGACGATT)

[0038] 2. Detailed screening process ( figure 1 )as follows:

[0039] Step 1: Take 1 nmol of ssDNA library strand and 5 nmol of complementary strand in 250 μL PBS (0.1M) buffer solution at 95°C for 5 min and then place at room temperature for 1 h;

[0040] Step 2: Take 200 μL streptavidin agarose balls to the micro-separation column, wash the streptavidin agarose balls in the separation column three times with PBS (200 μL / time), and then heat the denatured mixture Add to a miniature separation column and incubate with streptavidin agarose balls at room temperature for 10 min, collect the efflu...

Embodiment 2

[0053] Example 2: Construction of strand displacement biosensors.

[0054] The DNA sequence of FAM-HMX38 (FAM-CTCTCGGGCGAACGCGGGATGTTTGGGGGACCCACGTTCGCCC) tagged with FAM at the 5' end and cap38-BHQ1 (CGTTCGCCCGAGAG-BHQ1) tagged with BHQ1 at the 3' end was synthesized.

[0055] The synthesized DNA powders were all dissolved in PBS and quantified to 10 μM by Nanodrop. Take 10 μL of FAM-HMX38 (final concentration of 2 μM), 30 μL of cap38-BHQ1 (final concentration of 6 μM) and 10 μL of PBS, heat at 95 °C for 5 min, and then place at room temperature for 1 h. cap38-BHQ1 can complementarily pair with the 5' end of FAM-HMX38 to form strand displacement biosensor 38-3 (final concentration 2 μM, this concentration is based on FAM-HMX38), such as Figure 4 . Add different concentrations of MTX (0 μM, 0.1 μM, 0.2 μM, 0.5 μM, 1 μM, 2 μM) to the above sensor 38-3 (final concentration 0.1 μM), react at room temperature for 30 min, and measure with a microplate reader. Its fluorescence v...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an aptamer of methotrexate, an aptamer derivative and application of the aptamer and the aptamer derivative. A nucleotide sequence of the aptamer comprises DNA molecules as shown in sequences 1-5. The aptamer can be a derivative obtained from various similar sequences with high homology or derivatives provided by the invention. A method for detecting the methotrexate is established by utilizing the specific binding effect of the aptamer HMX38 and the methotrexate for the first time. The aptamer and the derivative thereof can be used for preparing methotrexate detection probes and drug carriers or used for drug design and development, drug separation and purification and the like. The aptamer and the derivative thereof have the advantages of being capable of being combined with methotrexate with high specificity and high affinity, free of immunogenicity, capable of being chemically synthesized, good in biocompatibility, small in molecular weight, stable, easy to store and the like.

Description

technical field [0001] The present invention relates to a nucleic acid aptamer, nucleic acid aptamer derivatives and applications thereof, in particular to a nucleic acid aptamer capable of binding methotrexate, a nucleic acid aptamer derivative and its ability to recognize and bind methotrexate Application of pterin. Background technique [0002] Methotrexate (MTX), a folic acid antagonist, is widely used in the clinical treatment of various cancers and inflammatory diseases. According to reports, nearly 700 kinds of cancer cells are sensitive to MTX, among which acute lymphoblastic leukemia cell lines and acute myeloid leukemia cell lines are the most sensitive to MTX. MTX can interfere with the synthesis of tetrahydrofolate, thereby inhibiting the synthesis of DNA and RNA in cells, thus playing an anti-tumor effect. However, MTX has the problems of narrow therapeutic window and large toxic and side effects. The adverse reactions induced by high-dose methotrexate (HDMTX)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/115G01N33/53
CPCC12N15/115G01N33/5308C12N2310/16
Inventor 施国跃何俊清汪俊彦张闽
Owner EAST CHINA NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com